235 related articles for article (PubMed ID: 27538126)
1. A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease.
Mekontso Dessap A; Pirenne F; Razazi K; Moutereau S; Abid S; Brun-Buisson C; Maitre B; Michel M; Galacteros F; Bartolucci P; Habibi A
Am J Hematol; 2016 Dec; 91(12):1181-1184. PubMed ID: 27538126
[TBL] [Abstract][Full Text] [Related]
2. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
3. Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.
Habibi A; Mekontso-Dessap A; Guillaud C; Michel M; Razazi K; Khellaf M; Chami B; Bachir D; Rieux C; Melica G; Godeau B; Galacteros F; Bartolucci P; Pirenne F
Am J Hematol; 2016 Oct; 91(10):989-94. PubMed ID: 27348613
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.
Narbey D; Habibi A; Chadebech P; Mekontso-Dessap A; Khellaf M; Lelièvre JD; Godeau B; Michel M; Galactéros F; Djoudi R; Bartolucci P; Pirenne F
Am J Hematol; 2017 Dec; 92(12):1340-1348. PubMed ID: 28924974
[TBL] [Abstract][Full Text] [Related]
5. Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
Gerritsma J; Bongaerts V; Eckhardt C; Heijboer H; Nur E; Biemond B; van der Schoot E; Fijnvandraat K;
Br J Haematol; 2022 Feb; 196(3):769-776. PubMed ID: 34632580
[TBL] [Abstract][Full Text] [Related]
6. Can we better predict delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease?
Adkins BD; Sharma D; Eichbaum Q
Transfus Apher Sci; 2020 Apr; 59(2):102681. PubMed ID: 31831326
[TBL] [Abstract][Full Text] [Related]
7. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
Gardner K; Hoppe C; Mijovic A; Thein SL
Br J Haematol; 2015 Sep; 170(6):745-56. PubMed ID: 25967919
[TBL] [Abstract][Full Text] [Related]
8. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.
Vidler JB; Gardner K; Amenyah K; Mijovic A; Thein SL
Br J Haematol; 2015 Jun; 169(5):746-53. PubMed ID: 25753472
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
Noizat-Pirenne F; Bachir D; Chadebech P; Michel M; Plonquet A; Lecron JC; Galactéros F; Bierling P
Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
[TBL] [Abstract][Full Text] [Related]
10. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.
Pirenne F; Yazdanbakhsh K
Blood; 2018 Jun; 131(25):2773-2781. PubMed ID: 29724898
[TBL] [Abstract][Full Text] [Related]
11. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells.
King KE; Shirey RS; Lankiewicz MW; Young-Ramsaran J; Ness PM
Transfusion; 1997 Apr; 37(4):376-81. PubMed ID: 9111274
[TBL] [Abstract][Full Text] [Related]
12. Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).
Thonier V
Transfus Clin Biol; 2019 May; 26(2):102-108. PubMed ID: 30885514
[TBL] [Abstract][Full Text] [Related]
13. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
Coleman S; Westhoff CM; Friedman DF; Chou ST
Transfusion; 2019 Jul; 59(7):2282-2291. PubMed ID: 31021439
[TBL] [Abstract][Full Text] [Related]
14. Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition.
Vlachaki E; Gavriilaki E; Kafantari K; Adamidou D; Tsitsikas D; Chasapopoulou E; Anagnostopoulos A; Tsapas A
Hemoglobin; 2018; 42(5-6):339-341. PubMed ID: 30626228
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
Fasano RM; Miller MJ; Chonat S; Stowell SR
Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199
[TBL] [Abstract][Full Text] [Related]
16. Anti-N and anti-Do
Unnikrishnan A; Pelletier JPR; Bari S; Zumberg M; Shahmohamadi A; Spiess BD; Michael MJ; Harris N; Harrell D; Mandernach MW
Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
[TBL] [Abstract][Full Text] [Related]
17. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
Chadebech P; Habibi A; Nzouakou R; Bachir D; Meunier-Costes N; Bonin P; Rodet M; Chami B; Galacteros F; Bierling P; Noizat-Pirenne F
Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729
[TBL] [Abstract][Full Text] [Related]
18. Utility of hemoglobin electrophoresis to distinguish between severe delayed hemolytic transfusion reaction versus hyperhemolysis syndrome.
Lukin R; Law JY; Lokhandwala PM
Transfus Apher Sci; 2024 Jun; 63(3):103919. PubMed ID: 38582651
[TBL] [Abstract][Full Text] [Related]
19. Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease: A Case Series.
Alwaheed AJ; Alqatari SG; AlSulaiman AS; AlSulaiman RS
Am J Case Rep; 2022 Jan; 23():e934681. PubMed ID: 34983921
[TBL] [Abstract][Full Text] [Related]
20. Preventing antibody positive delayed hemolytic transfusion reactions in sickle cell disease: Lessons learned from a case.
Rankin A; Webb J; Nickel RS
Transfus Med; 2022 Oct; 32(5):433-436. PubMed ID: 35318744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
